Physician profile
Eric M Shoemaker
NPI 1053554261
$788.84
in general payments reported to CMS, 2019-2025
12 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $24.72 · 2022: $92.98 · 2023: $403 · 2024: $55.74 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $198.25 | 2019-2025 | General - Pain Management |
| Abbott Laboratories | $139.90 | 2023 | Eterna |
| Abbvie INC. | $98.27 | 2023 | Botox |
| Relievant Medsystems, INC. | $96.43 | 2023 | Intracept |
| Nevro Corp. | $92.98 | 2022 | |
| Si-Bone, INC. | $50.61 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $24.72 | 2021 | |
| Organogenesis INC. | $23.47 | 2023 | Puraply |
| Biodelivery Sciences International, INC. | $18.09 | 2019 | |
| International Rehabilitative Sciences, INC | $17.51 | 2024 | Rs 4i Plus Sequential Stimulator |
| Globus Medical, INC. | $15.68 | 2024 | Allocate |
| Idorsia Pharmaceuticals US INC | $12.93 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shoemaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.